Blau Syndrome, the prototypic auto-inflammatory granulomatous disease

95Citations
Citations of this article
103Readers
Mendeley users who have this article in their library.

This artice is free to access.

Abstract

Blau syndrome is a monogenic disease resulting from mutations in the pattern recognition receptor NOD2, and is phenotypically characterized by the triad of granulomatous polyarthritis, dermatitis and uveitis. This paper reviews briefly the classical clinical features of the disease, as well as more recently described extra-triad symptoms. From an ongoing prospective multicenter study, we provide new data on the natural history of Blau syndrome, focusing on functional status and visual outcome. We also present an update of the range of different NOD2 mutations found in Blau syndrome as well as recent data on morphologic and immunohistochemical characteristics of the Blau granuloma. Finally, emerging insights into pathogenic mechanisms including activation of NOD2 signal transduction, and potential biomarkers of disease activity are discussed.

Cite

CITATION STYLE

APA

Wouters, C. H., Maes, A., Foley, K. P., Bertin, J., & Rose, C. D. (2014, August 6). Blau Syndrome, the prototypic auto-inflammatory granulomatous disease. Pediatric Rheumatology. BioMed Central Ltd. https://doi.org/10.1186/1546-0096-12-33

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free